Home/Filings/4/0001062993-21-006112
4//SEC Filing

ATP Life Science Ventures, L.P. 4

Accession 0001062993-21-006112

CIK 0001744659other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:31 PM ET

Size

7.0 KB

Accession

0001062993-21-006112

Insider Transaction Report

Form 4
Period: 2021-06-28
Transactions
  • Other

    Common Stock

    2021-06-285,830,2030 total
Transactions
  • Other

    Common Stock

    2021-06-285,830,2030 total
Footnotes (2)
  • [F1]The shares were distributed in a pro rata distribution to the limited partners of ATP Life Science Ventures, L.P. ("ATP," and formerly known as Apple Tree Partners IV, L.P.).
  • [F2]The shares were directly held by ATP. ATP III GP, Ltd. ("ATP GP") is the sole general partner of ATP. Seth L. Harrison is a director on the Issuer's board of directors and is the sole director of ATP GP. ATP GP and Dr. Harrison disclaim beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein.

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001593440

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:31 PM ET
Size
7.0 KB